Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Insulet Appoints Wayne A. I. Frederick, M.D., to Board of Directors
ACTON, Mass. --(BUSINESS WIRE)--Oct. 20, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that Wayne A. I.
View HTML
Toggle Summary Insulet to Announce Third Quarter 2020 Financial Results on November 4, 2020
ACTON, Mass. --(BUSINESS WIRE)--Oct. 5, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the third quarter of 2020 on
View HTML
Toggle Summary Insulet Expands its Offering of Omnipod DASH® Insulin Management System
ACTON, Mass. --(BUSINESS WIRE)--Sep. 21, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it is commercially launching its Omnipod DASH ® Insulin
View HTML
Toggle Summary Insulet to Present at Upcoming Investor Conferences
ACTON, Mass. --(BUSINESS WIRE)--Aug. 24, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two virtual investor conferences: The Baird 2020 Global
View HTML
Toggle Summary Insulet Reports Second Quarter 2020 Revenue Increase of 28% Year-Over-Year
Includes Total Omnipod ® Revenue Growth of 26% ACTON, Mass. --(BUSINESS WIRE)--Aug. 6, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial
View HTML
Toggle Summary Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020
ACTON, Mass. --(BUSINESS WIRE)--Jun. 29, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the second quarter of 2020 on
View HTML
Toggle Summary Insulet Installs Solar Panels at Its Global Headquarters and U.S. Manufacturing Facility to Help Reduce Its Carbon Footprint
ACTON, Mass. --(BUSINESS WIRE)--Jun. 24, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced its corporate headquarters and manufacturing facility in Acton, MA ,
View HTML
Toggle Summary Insulet Presents Omnipod Virtual Care Experience and Pre-Pivotal Study Results at the American Diabetes Association 80th Scientific Sessions
ACTON, Mass. --(BUSINESS WIRE)--Jun. 11, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced its robust schedule of events for the American Diabetes Association
View HTML
Toggle Summary Insulet Resumes Pivotal Study of its Next-Generation Product - Omnipod, Powered by Horizon™
ACTON, Mass. --(BUSINESS WIRE)--Jun. 5, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced it has resumed its pivotal study of Omnipod, Powered by Horizon™, the
View HTML
Toggle Summary Insulet to Present at Upcoming Investor Conferences
ACTON, Mass. --(BUSINESS WIRE)--May 28, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming virtual investor conferences: The Piper
View HTML
Toggle Summary Insulet Corporation Announces Pricing of $500 Million Public Offering of Common Stock
ACTON, Mass. --(BUSINESS WIRE)--May 12, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), a global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced the pricing of its $500 million common stock registered
View HTML
Toggle Summary Insulet Corporation Announces Plans for Public Offering of Common Stock
ACTON, Mass. --(BUSINESS WIRE)--May 12, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), a global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that it plans to make an offering of $500 million of its
View HTML
Toggle Summary Presentation for Insulet Public Offering of Common Stock
Toggle Summary Insulet to Present at Upcoming Investor Conferences
ACTON, Mass. --(BUSINESS WIRE)--May 8, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences: The BofA Securities
View HTML
Toggle Summary Insulet Reports First Quarter 2020 Revenue Increase of 24% Year-Over-Year
Includes Total Omnipod Revenue Growth of 33% ACTON, Mass. --(BUSINESS WIRE)--May 7, 2020-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial
View HTML